p3 trial was supposed to enrol 300 patients by 30 June 2023 as announced in january 2023. so far it doesn't appear anywhere close to this and the company is having major issues getting its drug right for the trial. looking likely to be at least another 6 months before we see the results. a massive failure on the part of the company. the clinics were supposed to improve the patient recruitment process but obviously outsourcing the drug side of the trial turned into a mess as well. meanwhile cbd is no longer a hot talking point anymore and tattarang are down hugely on their investment.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $15.89M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.6¢ | $32.17K | 1.164M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 474329 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 702242 | 4 |
View Market Depth
| Last trade - 16.10pm 02/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |